Evidence map›Paper›PMID 38924467›Full record

ArticleCancer research2024

Multistate Gene Cluster Switches Determine the Adaptive Mitochondrial and Metabolic Landscape of Breast Cancer.

Michela Menegollo, Robert B Bentham, Tiago Henriques, Seow Q Ng, Ziyu Ren, Clarinde Esculier, Sia Agarwal, Emily T Y Tong, Clement Lo, Sanjana Ilangovan and 8 more

Abstract read
In one paragraph

Article in Cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Michela MenegolloDepartment of Biomedical Sciences, University of Padova, Padova, Italy.ORCID 0000-0003-3918-1956
Robert B BenthamDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0000-0003-0487-8980
Tiago HenriquesDepartment of Biomedical Sciences, University of Padova, Padova, Italy.ORCID 0000-0001-6075-2368
Seow Q NgDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0000-0001-8391-7233
Ziyu RenDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0009-0002-8167-0905
Clarinde EsculierDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0009-0006-4518-1003
Sia AgarwalDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0009-0006-5273-3304
Emily T Y TongDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0009-0005-2418-5534
Clement LoDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0009-0006-5704-441X
Sanjana IlangovanDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0000-0002-3429-3986
Zorka SzabadkaiDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0009-0003-7120-975X
Matteo SumanDepartment of Biomedical Sciences, University of Padova, Padova, Italy.ORCID 0009-0003-3697-9249
Neill PataniDepartment of Cell and Developmental Biology, Consortium for Mitochondrial Research, University College London, London, United Kingdom.ORCID 0000-0002-9591-8636
Avinash GhanateThe Francis Crick Institute, London, United Kingdom.ORCID 0000-0002-6284-7667
Kevin BrysonDepartment of Computer Sciences, University College London, London, United Kingdom.ORCID 0000-0002-1163-6368
Robert C SteinDepartment of Oncology, University College London Hospitals, London, United Kingdom.ORCID 0000-0003-2969-0415
Mariia YunevaThe Francis Crick Institute, London, United Kingdom.ORCID 0000-0003-3455-9374
Gyorgy SzabadkaiDepartment of Biomedical Sciences, University of Padova, Padova, Italy.ORCID 0000-0002-3006-3577

Funding

Biotechnology and Biological Sciences Research Council (BBSRC) BB/L020874/1Biotechnology and Biological Sciences Research Council (BBSRC) BB/P018726/1British Heart Foundation (BHF) FS/20/4/34958Cancer Research UK (CRUK) 29264Cancer Research UK (CRUK) C57633/A25043Fondazione AIRC per la ricerca sul cancro ETS (AIRC) IG22221Fondazione AIRC per la Ricerca sul Cancro ETS (AIRC) IG13447Francis Crick Institute (FCI) FC0010060UCLH Biomedical Research Centre (UCL)Wellcome Trust FC001223Wellcome Trust (WT) 204458/Z/16/Z
6 · The paper itself

Abstract

Adaptive metabolic switches are proposed to underlie conversions between cellular states during normal development as well as in cancer evolution. Metabolic adaptations represent important therapeutic targets in tumors, highlighting the need to characterize the full spectrum, characteristics, and regulation of the metabolic switches. To investigate the hypothesis that metabolic switches associated with specific metabolic states can be recognized by locating large alternating gene expression patterns, we developed a method to identify interspersed gene sets by massive correlated biclustering and to predict their metabolic wiring. Testing the method on breast cancer transcriptome datasets revealed a series of gene sets with switch-like behavior that could be used to predict mitochondrial content, metabolic activity, and central carbon flux in tumors. The predictions were experimentally validated by bioenergetic profiling and metabolic flux analysis of 13C-labeled substrates. The metabolic switch positions also distinguished between cellular states, correlating with tumor pathology, prognosis, and chemosensitivity. The method is applicable to any large and heterogeneous transcriptome dataset to discover metabolic and associated pathophysiological states. Significance: A method for identifying the transcriptomic signatures of metabolic switches underlying divergent routes of cellular transformation stratifies breast cancer into metabolic subtypes, predicting their biology, architecture, and clinical outcome.

Indexed as

Breast NeoplasmsMitochondriaMultigene FamilyEnergy MetabolismFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansPrognosisTranscriptome

Identifiers

PMID38924467
PMCPMC11372374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.